Downregulation of LAPTM4B Contributes to the Impairment of the Autophagic Flux via Unopposed Activation of mTORC1 Signaling During Myocardial Ischemia/Reperfusion Injury

• Published in: Circulation research Vol. 127; no. 7; pp. e148 - e165
• Main Authors: Gu, Shanshan, Tan, Jiliang, Li, Qiang, Liu, Shenyan, Ma, Jian, Zheng, Yanjun, Liu, Jinlong, Bi, Wei, Sha, Ping, Li, Xuxia, Wei, Meng, Cao, Nan, Yang, Huang-Tian
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 11.09.2020
• Subjects: Animals; Autophagosomes - genetics; Autophagosomes - metabolism; Autophagosomes - pathology; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism; Cells, Cultured; Disease Models, Animal; Down-Regulation; Lysosomes - genetics; Lysosomes - metabolism; Lysosomes - pathology; Male; Mechanistic Target of Rapamycin Complex 1 - metabolism; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Myocardial Infarction - genetics; Myocardial Infarction - metabolism; Myocardial Infarction - pathology; Myocardial Infarction - prevention & control; Myocardial Reperfusion Injury - genetics; Myocardial Reperfusion Injury - metabolism; Myocardial Reperfusion Injury - pathology; Myocardial Reperfusion Injury - prevention & control; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; Rats, Sprague-Dawley; Sequestosome-1 Protein - metabolism; Signal Transduction; lysosomes; autophagy; autophagosomes; mice; heart
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/CIRCRESAHA.119.316388

RATIONALE:Impaired autophagic flux contributes to ischemia/reperfusion (I/R)-induced cardiomyocyte death, but the underlying molecular mechanisms remain largely unexplored. OBJECTIVE:To determine the role of LAPTM4B (lysosomal-associated transmembrane protein 4B) in the regulation of autophagic flux and myocardial I/R injury. METHODS AND RESULTS:LAPTM4B was expressed in murine hearts but downregulated in hearts with I/R (30 minutes/2 hours) injury and neonatal rat cardiomyocytes with hypoxia/reoxygenation (6 hours/2 hours) injury. During myocardial reperfusion, LAPTM4B-knockout (LAPTM4B) mice had a significantly increased infarct size and lactate dehydrogenase release, whereas adenovirus-mediated LAPTM4B-overexpression was cardioprotective. Concomitantly, LAPTM4B mice showed higher accumulation of the autophagy markers LC3-II (microtubule-associated protein 1A/1B-light chain 3), but not P62, in the I/R heart, whereas they did not alter chloroquine-induced further increases of LC3-II and P62 in both sham and I/R hearts. Conversely, LAPTM4B-overexpression had opposite effects. The hypoxia/reoxygenation–reduced viability of neonatal rat cardiomyocytes, ratio of autolysosomes/autophagosomes, and function of lysosomes were further decreased by LAPTM4B-knockdown but reversed by LAPTM4B-overexpression. Moreover, the LAPTM4B-overexpression–mediated benefits were abolished by knockdown of lysosome-associated membrane protein-2 (an autophagosome-lysosome fusion protein) in vivo and by the autophagy inhibitor bafilomycin A1 in vivo. In contrast, rapamycin (Rapa) successfully restored the impaired autophagic flux in LAPTM4B mice and the subsequent myocardial I/R injury. Mechanistically, LAPTM4B regulated the activity of mTORC1 (mammalian target of rapamycin complex 1) via interacting with mTOR through its EC3 (extracelluar) domain. Thus, mTORC1 was overactivated in LAPTM4B mice, leading to the repression of TFEB (transcription factor EB), a master regulator of lysosomal and autophagic genes, during myocardial I/R. The mTORC1 inhibition or TFEB-overexpression rescued the LAPTM4B-induced impairment in autophagic flux and I/R injury, whereas TFEB-knockdown abolished the LAPTM4B-overexpression–mediated recovery of autophagic flux and cardioprotection. CONCLUSIONS:The downregulation of LAPTM4B contributes to myocardial I/R–induced impairment of autophagic flux via modulation of the mTORC1/TFEB pathway.